1 year return (CAGR)
-25.13%
Biomea Fusion Inc Exchange (NASDAQ, USD)
BMEA
1.49
+0.05 (+3.47%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-53.69%
5 year return (CAGR)
-34.62%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
107.73M
Price/Sales
-
Ent value
97.64M
Price/Book
8.88
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
18.93%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.46 |
| Daily high | 1.50 |
| Daily low | 1.39 |
| Daily Volume | 2.18M |
| All-time high | 41.80 |
| 1y analyst estimate | 6.50 |
| Beta | -0.30 |
| EPS (TTM) | -0.45 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 6 Apr 2026 |
Downside potential
Loading...
Downside potential data
| BMEA | S&P500 | |
| Current price drop from All-time high | -96.44% | -1.38% |
| Highest price drop | -97.71% | -56.47% |
| Date of highest drop | 2 Dec 2025 | 9 Mar 2009 |
| Avg drop from high | -68.33% | -10.68% |
| Avg time to new high | 68 days | 12 days |
| Max time to new high | 827 days | 1805 days |
News
